These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4372272)

  • 21. [Antibacterial effects of niridazole. II. Effects on aerobic and anaerobic bacteria].
    Hof H; Müller KM
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):265-71. PubMed ID: 6299027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility testing of anaerobic bacteria.
    Citron D
    Am J Med Technol; 1983 Nov; 49(11):769-72. PubMed ID: 6316785
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of medium and inoculum on antimicrobial susceptibility of anaerobic bacteria.
    Rahimi A; Martin WJ; Washington JA
    Am J Clin Pathol; 1974 Sep; 62(3):425-7. PubMed ID: 4496770
    [No Abstract]   [Full Text] [Related]  

  • 25. A note on the antibiotic susceptibilities of Clostridium perfringens serotypes isolated from meat.
    Smart JL; Truman ML; Stringer MF
    J Appl Bacteriol; 1983 Feb; 54(1):135-9. PubMed ID: 6303997
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro susceptibility of bacteroides strains to tetracycline, chloramphenicol, doxycycline, and clindamycin.
    Monif GR; Baer H
    Obstet Gynecol; 1974 Feb; 43(2):211-4. PubMed ID: 4589458
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens.
    Stevens DL; Maier KA; Laine BM; Mitten JE
    J Infect Dis; 1987 Feb; 155(2):220-8. PubMed ID: 2879873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy of experimental (murine) Clostridium perfringens type A gas gangrene.
    Traub WH
    Chemotherapy; 1988; 34(6):472-7. PubMed ID: 2907452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
    Nord CE; Olsson-Liljequist B
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():183-8. PubMed ID: 2863246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standardized antimicrobial disc susceptibility testing of anaerobic bacteria: in vitro susceptibility of Clostridium perfringens to nine antibiotics.
    Sapico FL; Kwok YY; Sutter VL; Finegold SM
    Antimicrob Agents Chemother; 1972 Oct; 2(4):320-5. PubMed ID: 4363787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg.
    van der Westhuyzen I; Chalkley LJ
    S Afr Med J; 1992 Nov; 82(5):314-7. PubMed ID: 1448710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms.
    Nachnani S; Scuteri A; Newman MG; Avanessian AB; Lomeli SL
    J Periodontol; 1992 Jul; 63(7):576-83. PubMed ID: 1324301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility to erythromycin of anaerobes of the genera Bacteroides, Fusobacterium, Sphaerophorus, Veillonella, Clostridium, Corynebacterium, Peptococcus, Peptostreptococcus.
    Werner H; Boehm M; Kunstek-Santos H; Lohner C; Jordan T
    Arzneimittelforschung; 1977; 27(12):2263-5. PubMed ID: 580038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs.
    Sutter VL; Finegold SM
    J Infect Dis; 1975 Apr; 131(4):417-22. PubMed ID: 804023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardized antimicrobial disc susceptibility testing of anaerobic bacteria. I. Susceptibility of Bacteroides fragilis to tetracycline.
    Sutter VL; Kwok YY; Finegold SM
    Appl Microbiol; 1972 Feb; 23(2):268-75. PubMed ID: 5017675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
    Watt B; Naden MG
    Chemioterapia; 1988 Aug; 7(4):264-6. PubMed ID: 2902937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic treatment of oral anaerobic infections.
    Olson RE; Morello JA; Kieff ED
    J Oral Surg; 1975 Aug; 33(8):619-21. PubMed ID: 1056466
    [No Abstract]   [Full Text] [Related]  

  • 38. [In vitro susceptibility of Clostridium perfringens to 6 antimicrobial agents].
    Fernández H; Toledo G
    Rev Med Chil; 1982 Nov; 110(11):1110-2. PubMed ID: 6306749
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sensitivity of anaerobes to 8 antibiotics].
    Sedallian A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):645-7. PubMed ID: 3534760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aridicins, novel glycopeptide antibiotics. III. Preparation, characterization, and biological activities of aglycone derivatives.
    Sitrin RD; Chan GW; Chapin F; Giovenella AJ; Grappel SF; Jeffs PW; Phillips L; Snader KM; Nisbet LJ
    J Antibiot (Tokyo); 1986 Jan; 39(1):68-75. PubMed ID: 2869019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.